Anavex Life Sciences Newsroom

H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $40

Futu News19:31

Anavex Life Sciences Is Maintained at Buy by D. Boral Capital

Dow JonesNov 25 22:16

Anavex Life Sciences Price Target Maintained With a $46.00/Share by D. Boral Capital

Dow JonesNov 25 22:16

H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $40

Futu NewsNov 4 19:31

Anavex Life Sciences Analyst Ratings

BenzingaNov 4 19:30

HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $40 Price Target

BenzingaNov 4 19:30

Anavex Life Sciences: Buy Rating Driven by Promising Blarcamesine Developments and Market Expansion

TipRanksNov 4 19:17

JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15

Futu NewsOct 31 23:32

Anavex Life Sciences Is Maintained at Buy by EF Hutton

Dow JonesOct 31 21:13

Anavex Life Sciences Analyst Ratings

BenzingaOct 18 19:04

H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $40

Futu NewsOct 18 18:37

Buy Rating on Anavex Life Sciences Amid Anticipated European Approval and Market Opportunity for Alzheimer's Drug Blarcamesine

TipRanksAug 7 18:41

JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15

Futu NewsAug 7 02:31

Buy Rating on Anavex Life Sciences: Upcoming Catalysts and Positive Trial Outcomes Fuel Optimism

TipRanksAug 7 01:48

HC Wainwright & Co. Reiterates Buy on Anavex Life Sciences, Maintains $40 Price Target

BenzingaAug 1 18:13

Anavex Life Sciences Analyst Ratings

BenzingaAug 1 18:11

H.C. Wainwright Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $40

Futu NewsJul 31 20:31

Buy Rating Affirmed for Anavex Life Sciences on Blarcamesine's Promising Alzheimer's Treatment Potential

TipRanksJul 31 20:20

JonesTrading Maintains Anavex Life Sciences(AVXL.US) With Buy Rating, Maintains Target Price $15

Futu NewsJul 29 20:31

Buy Rating Affirmed: Anavex Life Sciences' Promising Alzheimer's Drug Shows Potential for Approval

TipRanksJul 29 20:23